436
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Serum biochemical markers of central nerve system damage in children with acute elemental mercury intoxicatıon

, , , , , & show all
Pages 32-38 | Received 31 Jul 2013, Accepted 25 Oct 2013, Published online: 09 Jan 2014

References

  • Tezer H, Kaya A, Kalkan G, Erkocoglu M, Ozturk K, Buyuktasli M. Mercury poisoning: a diagnostic challenge. Pediatr Emerg Care 2012; 28:1236–1237.
  • Weinstein M, Bernstein S. Pink ladies: mercury poisoning in twin girls. CMAJ 2003; 168:201.
  • van der Linde AA, Lewiszong-Rutjens CA, Verrips A, Gerrits GP. A previously healthy 11-year-old girl with behavioural disturbances, desquamation of the skin and loss of teeth. Eur J Pediatr 2009; 168:509–511.
  • Jones L, Bunnell J, Stillman J. A 30-year follow-up of residual effects on New Zealand School Dental Nurses, from occupational mercury exposure. Hum ExpToxicol 2007; 26:367–374.
  • Whitfield JB, Dy V, McQuilty R, Zhu G, Heath AC, Montgomery GW, Martin NG. Genetic effects on toxic and essential elements in humans: arsenic, cadmium, copper, lead, mercury, selenium, and zinc in erythrocytes. Environ Health Perspect 2010; 118:776–782.
  • Mason HJ, Hindell P, Williams NR. Biological monitoring and exposure to mercury. Occup Med (Lond) 2001; 51:2–11.
  • Carman KB, Tutkun E, Yilmaz H, Dilber C, Dalkiran T, Cakir B, et al. Acute mercury poisoning among children in two provinces of Turkey. Eur J Pediatr 2013; 172:821–827.
  • Friberg L, Mottet NK. Accumulation of methylmercury and inorganic mercury in the brain. Biol Trace Elem Res 1989; 21:201–351.
  • Liu J, Goyer RA, Waalkes MP. Toxic effects of metals. In: Casarett LJ, Doull J, Klaassen CD, eds. Casarett and Doull's Toxicology: The Basic Science of Poisons. 7th ed. New York: McGraw-Hill; 2008:931–979.
  • Wiesmann M, Missler U, Hagenstrom H, Gottmann D. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage,Acta Neurochir (Wien) 1997; 139:1155–1160.
  • Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30:1190–1195.
  • Huang J, Tanii H, Kato K, Hashimoto K. Neuron and glial cell marker proteins as indicators of heavy metal-induced neurotoxicity in neuroblastoma and glioma cell lines. Arch Toxicol 1993; 67:491–496.
  • Kozik MB, Wygladalska H. Enzymatic activity of hydrolases in the spinal cord of rat after an acute and subacute calomel intoxication. Folia Histochem Cytochem (Krakow) 1977; 15:79–85.
  • Petroff OA. GABA and glutamate in the human brain. Neuroscientist 2002; 8:562–573.
  • Basu N, Scheuhammer AM, Rouvinen-Watt K, Grochowina N, Evans RD, O’Brien M, Chan HM. Decreased N-methyl-D-aspartic acid (NMDA) receptor levels are associated with mercury exposure in wild and captive mink. Neurotoxicology 2007; 28:587–593.
  • Simmons-Willis TA, Koh AS, Clarkson TW, Ballatori N. Transport of a neurotoxicant by molecular mimicry: The methyl mercury- l-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT-2. Biochem J 2002; 367:239–246.
  • Frumkin FH, Letz R, Williams PL, Gerr F, Pierce M, Sanders AQ. Health effects of long-term mercury exposure among chlor alkali plant workers. Am J Ind Med 2001; 39:1–8.
  • Ritchie KA, Gilmour WH, Macdonald EB, Burke FJ, Mc-Gowan DA, Dale IM, et al. Health and neurophysiological functioning of dentists exposed to mercury. Occup Environ Med 2002; 59:287–293.
  • Aydın N, Karaoğlanoğlu S, Yiğit A, Keles MS, Kırkpınar I, Seven N. Neurophysiological effects of low mercury exposure in dental staff in Erzurum, Turkey. Int Dent J 2003; 53:85–91.
  • Dare E, Gorman AM, Ahlbom M, Gotz T, Momoi T, Ceeatelli S. Apopitotic morphology does not always require caspase activity in rat cerebellar granüle neurons. Neurotox Res 2001; 3:501–514.
  • Vilagi I, Docziand J, Banczerowski-Pelyhe I. Altered electrophysiological characteristics of developing rat cortical neurones after chronic methyl mercury chloride treatment. Int J Dev Neurosci 2000; 18:493–499.
  • Duszczyk-Budhathoki M, Olczak M, Lehner M, Majewska D. Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate. Neurochem Res 2012; 37:436–447.
  • Sacaan AI, Schoepp DD. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neuroscience Lett 1992; 139:77–81.
  • Santiago AR, Gaspar JM, Baptista FI, Cristóvão AJ, Santos PF, Kamphuis W, Ambrósio AF. Diabetes changes the levels of ionotropic glutamate receptors in the rat retina. Mol Vis 2009; 15:1620–1630.
  • Xu J, Yan HC, Yang B, Tong LS, Zou YX, Tian Y. Effects of lead exposure on hippocampal metabotropic glutamate receptor subtype 3 and 7 in developmental rats. J Negat Results Biomed 2009; 8:5.
  • Nihei MK, Guilarte TR. Molecular changes in glutamatergic synapses induced by Pb2+: association with deficits of LTP and spatial learning. Neurotoxicology 2001; 22:635–643.
  • Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev. 1999; 51:57–61.
  • Schreiber SS, Baudry M. Selective neuronal vulnerability in the hippocampus–a role for gene expression?Trends Neurosci 1995; 18:446–451.
  • Nihei MK, Desmond NL, McGlothan JL, Kuhlmann AC, Guilarte TR. N-methyl-D-aspartate receptor subunit changes are associated with lead-induced deficits of long-term potentiation and spatial learning. Neuroscience 2000; 99:233–242.
  • Trudeau F, Gagnon S, Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 2004; 490:177–186.
  • Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330:613–622.
  • Vives V, Alonso G, Solal AC, Joubert D, Legraverend C. Visualization of S100B-positive neurons and glia in the central nervous system of EGFP trangenic mice. J Comp Neurol 2003; 457:404–419.
  • Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech 2003; 60:614–632.
  • Farina M, Cereser V, Portela LV, Mendez A, Porciuncula LO, Fornaguera J, et al. Methyl mercury incrases S100B content in rat cerebrospinal fluid. Environ Toxicol Pharmacol 2005; 19:249–253.
  • Vicente E, Boer M, Leite M, Silva M, Tramontina F, Porciuncula L, et al. Cerebrospinal fluid S100B increases reversibly in neonates of methyl mercury-intoxicated pregnant rats. Neurotoxicology 2004; 25:771–777.
  • Homolkova H, Prchlik M, Tomek P. The relationship between S100B protein serum levels, injury severity and Glasgow Outcome Scale values in children with CNS injuries. Neuro Endocrinol Lett 2012; 33:207–211.
  • van Munster BC, Korse CM,de Rooij SE, Bonfrer JM, Zwinderman AH, Korevaar JC. Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol 2009; 9:21.
  • Benz MR, Lee SH, Kellner L, Döhlemann C, Berweck S. Hyperintense lesion in brain MRI after exposure to a mercuric chloride-containing skin whitening cream. Eur J Pediatr 2011; 170:747–750.
  • Donato R. Functional roles of S100 proteins calcium binding proteins of the EF-hand type. Biochim Biophys Acta 1999; 1450:191–231.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.